QurAlis

QurAlis

  • Founded: 2016
  • Location: Cambridge, MA
  • Employee range: 11 - 50
  • Clinical stage: Clin1
  • Therapy area: ALS
  • Drug types: NEU
  • Lead product: QRL-201
  • Product link: https://quralis.com/pipeline/
  • Funding: $88M B Mar 2023; $42M May 2020; $5.5M Seed Nov 2018
  • Investors: EQT Life Sciences, Droia Ventures, Sanofi Ventures, BioInnovation Capital, Viva Biotech Limited, Alexandria, Amgen, MP Healthcare Venture Management, ALS Investment Fund, LS Polaris Innovation Fund, Mission BioCapital, INKEF Capital, Dementia Discovery Fund, Amgen Ventures, MP Healthcare Venture Management, Mitsui Global Investment, Dolby Family Ventures, Mission Bay Capital, Sanford Biosciences


quralis.com

linkedin.com

job board


Short description:

ALS cure - Small Molecules, ASO

Drug notes:

QRL-201/QRL-203 Clin0 FTD, Clin0 PLS; QRL-101 Clin1 ALS, Clin0 FTD; QRL-204 Clin0 ALS/FTD, Clin0 FTD

Long description:

Contact us to add description: recruit@workinbiotech.com

Jobs:

QurAlis
Associate Scientist
Cambridge, MA|30 days ago
Apply


© 2024 Work In Biotech LLC
Personal data

Terms of Service

Privacy Policy

Contact: recruit@workinbiotech.com